Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Allan C. Silber currently holds 38,087 shares of POINT Biopharma Global Inc. (PNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allan C. Silber has been a net seller of PNT stock. They have purchased $1.9M and sold $2.5M worth of shares.
Allan C. Silber's most recent insider trade was on Dec 22, 2023, when they sold 4,035,655 shares at $0.00 per share.
Allan C. Silber serves as Executive at POINT Biopharma Global Inc. (PNT). They have executed 82 insider transactions totaling $4.4M over their tenure at the company.
Allan C. Silber holds the position of Executive at POINT Biopharma Global Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Allan C. Silber has shown a selling trading pattern, with $1.9M in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Allan C. Silber was on Mar 22, 2021, when they sold $747.5K worth of HGBL shares. This transaction involved 250,000 shares at $2.99 per share.
Allan C. Silber currently owns 38,087 shares of POINT Biopharma Global Inc. (PNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Allan C. Silber's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Allan C. Silber has 82 Form 4 filings on record as an insider at POINT Biopharma Global Inc..
Set alerts for Allan C. Silber and 40,000+ other insiders.